UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 3, 2004
NovaMed, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware |
0-26625 |
36-4116193 |
|
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer Identification No.) |
|
980 North Michigan Avenue, Suite 1620, Chicago, Illinois |
60611 |
|
(Address of Principal Executive Offices) |
(Zip Code) |
Registrant’s telephone number, including area code (312) 664-4100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Section 2 - Financial Information
Item 2.02 Results of Operations and Financial Condition.
On November 3, 2004, NovaMed, Inc. issued a press release announcing its results of operations for the period ended September 30, 2004. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
Exhibit Number Title
99.1 Press release of NovaMed, Inc. dated
November 3, 2004
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NovaMed, Inc.
Dated: November 3, 2004 By: /s/ Stephen J. Winjum
Stephen J. Winjum
President and Chief Executive Officer
EXHIBIT INDEX
Exhibit No. Exhibit
99.1 Press release of NovaMed, Inc. dated November 3, 2004